Herramientas de accesibilidad
Herramientas de servicio
Selección de idiomas
Recorrido de navegación
II - Grupos de presión dentro de las empresas y asociaciones comerciales, empresariales o profesionales
Asociaciones comerciales y empresariales
avenue de l'Armée, 6
EuropaBio's mission is to create an innovative and dynamic biotechnology industry in Europe by communicating the benefits of biotech to all corners of society. The association works in all of the application fields of modern biotechnology, including healthcare, agriculture and food production, and industrial biotechnology.
Members of EuropaBio are involved in research, development, testing, manufacturing and commercialisation of biotechnology products and processes. Our corporate members have a wide range of activities: human and animal health care, diagnostics, bio-informatics, chemicals, crop protection, agriculture, food and environmental products and services.
EuropaBio also welcomes associate members such as international commercial, financial, asset management and other service-providing companies, regional biotechnology development organisations and scientific institutes. The common denominator among all our members is the use of biotechnology at any stage of research, development or manufacturing.
We stand for free and open markets and the removal of barriers to competitiveness with other areas of the world.
We are committed to open, informed communications with all stakeholders and the general public about the ethical, social and economic aspects of biotechnology and its applications.
We champion the responsible use of biotechnology to ensure that its potential is fully used to the benefit of the environment and mankind.
Sectors of particular interest include: agricultural, food, healthcare, environmental, industrial and innovation policy. As biotechnology is strongly based on innovation developed in start-up and small companies, policies related to the promotion of SMEs in the EU are a focus of attention. Biotechnology is a knowledge-based sector, and policies related to intellectual property rights are another important focus of attention.
Bioeconomy Strategy and action plan
GMO legislation and review of legislation
Regulation on Advanced Therapy Medicinal Products
Directive 98/44/EC on the legal protection of biotechnological inventions
Clinical Trials Directive
Main policy areas of interest in the last year:
• All EU policy tracks related to pharmaceuticals, their regulation and access, and to the development of an innovative EU healthcare biotech sector.
• All EU policy tracks related to regulation affecting the use of modern biotechnology in agriculture, environment and food
• All EU policy tracks related to the development of the bio-based economy (e.g. agricultural policy, research and innovation, industry and competitiveness, environment, climate change, trade, energy and transport, etc.).
• SME policy
• All policy developments related to intellectual property rights
9 people on the basis of staff time ( prorata in percentage)
on 20% and 5% of their time: 105% = 1FTE
|Nombre||Apellidos||Fecha inicial||Fecha final|
01/2014 - 12/2014
>= 200.000 € y < 299.999 €
EuropaBio is involved in one FP7 project with Eu funding and 97% income comes from membership fees.
Al inscribirse, la organización ha firmado el código de conducta del Registro de Transparencia.
La organización también ha declarado que está vinculada al siguiente código:
EuropaBio's Core Ethical Values Charter: http://www.europabio.org/core-ethical-value